SCHEMBL12359264

SCHEMBL12359264

CS(=O)(=O)Nc1ccccc1-c1ccc2[nH]c(-c3ccc(OCC(F)(F)F)cc3)nc2c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 9/20 0.65
BRD4 O60885 2/20 0.44
ALOX5AP P20292 3/20 0.42
FEN1 P39748 3/20 0.42
METAP2 P50579 1/20 0.42
MAPT P10636 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ACHE P22303 2/20 0.40
CHEK2 O96017 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14389143 0.93 TRPV1 (0.57) TRPV1BRD4ALOX5APFEN1METAP2
SCHEMBL12359271 0.91 TRPV1 (0.54) TRPV1ALOX5APFEN1MAPTHDAC3
SCHEMBL1799145 0.88 TRPV1 (0.62) TRPV1BRD4ALOX5APFEN1METAP2
SCHEMBL1797283 0.87 TRPV1 (0.61) TRPV1BRD4ALOX5APFEN1METAP2
SCHEMBL1799933 0.86 TRPV1 (0.88) TRPV1
SCHEMBL1799932 0.86 TRPV1 (0.88) TRPV1
SCHEMBL12359207 0.85 TRPV1 (0.50) TRPV1BRD4ALOX5APFEN1CHEK2
SCHEMBL1795778 0.84 TRPV1 (0.58) TRPV1BRD4ALOX5APFEN1METAP2
SCHEMBL12358855 0.84 TRPV1 (0.47) TRPV1ALOX5APFEN1MAPTHDAC3
SCHEMBL12358702 0.82 TRPV1 (0.54) TRPV1BRD4ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2011-08-04 US disclosed
US-7951829-B2 Benzimidazole modulators of VR1 JANSSEN PHARMACEUTICA NV (BE) 2011-05-31 US disclosed
US-20070259936-A1 Benzimidazole Modulators of VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259936-A1 Benzimidazole Modulators of VR1 VRK1, VRK2, VIL1 TRPV1 29/4885BRD4 405/4885ALOX5AP 3512/4885
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 VRK1, VRK2, VIL1 TRPV1 29/4885BRD4 405/4885ALOX5AP 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.